nach oben

Erschienen in:

16.10.2021 | Sleep Breathing Physiology and Disorders • Review

Association between YKL-40 and asthma: a systematic meta-analysis

verfasst von: Yihan Jin, Jie Song, Fang Xu, Di Zhang, Jinfang He, Jiakun Zheng, Yanan Zhang, Jintong Li, Yikun Guo, Mengjiao Xu, Xiangfeng Yu, Yanbin Liu, Qinghua Liu, Jun Yan

Erschienen in: Sleep and Breathing | Ausgabe 3/2022

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Many studies have shown that chitinase-3-like protein 1 (CHI3L1), also known as YKL-40, is associated with asthma. The purpose of this meta-analysis was to evaluate the role of serum YKL-40 in the diagnosis and differential diagnosis of asthma, severity grading, and determination of disease state.

Methods

The PubMed, Ovid, and Cochrane databases were searched. A total of 17 articles involving 5696 subjects were included in this meta-analysis.

Results

The results showed that the level of YKL-40 was significantly higher in asthmatic patients than in the normal group regardless of age and residential location, and increased with severity and acute exacerbation (p < 0.05). YKL-40 levels were significantly different between chronic obstructive pulmonary disease (COPD) and asthma, and also between asthma-COPD overlap syndrome (ACO) and asthma (p < 0.05).

Conclusion

YKL-40 may act as a potential serological marker for the diagnosis of asthma, assessment of severity, indicator of the disease state, and differential diagnosis of COPD, ACO, and asthma.

Boot RG, Blommaart EF, Swart E et al (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase[J]. J Biol Chem 276(9):6770–6778PubMedCrossRef

Dickey BF (2007) Exoskeletons and exhalation[J]. N Engl J Med 357(20):2082–2084PubMedCrossRef

Leung TF, Ching KW, Sy HY et al (2010) CHIA confers susceptibility to childhood eczema[J]. Br J Dermatol 163(6):1360–1362PubMedCrossRef

Lin HW, Chiang YC, Sun NY et al (2019) CHI3L1 results in poor outcome of ovarian cancer by promoting properties of stem-like cells[J]. Endocr Relat Cancer 26(1):73–88PubMedCrossRef

Furuhashi K, Suda T, Nakamura Y et al (2010) Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis[J]. Respir Med 104(8):1204–1210PubMedCrossRef

Kuepper M, Bratke K, Virchow JC (2008) Chitinase-like protein and asthma[J]. N Engl J Med 358(10):1073–1075, 1075PubMedCrossRef

Wang J, Lv H, Luo Z et al (2018) Plasma YKL-40 and NGAL are useful in distinguishing ACO from asthma and COPD[J]. Respir Res 19(1):47PubMedPubMedCentralCrossRef

Specjalski K, Chelminska M, Jassem E (2015) YKL-40 protein correlates with the phenotype of asthma[J]. Lung 193(2):189–194PubMedPubMedCentralCrossRef

Gomez JL, Crisafi GM, Holm CT et al (2015) Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40[J]. J Allergy Clin Immunol 136(1):51–58PubMedPubMedCentralCrossRef

10.

Kim SH, Choi H, Yoon MG et al (2015) Dipeptidyl-peptidase 10 as a genetic biomarker for the aspirin-exacerbated respiratory disease phenotype[J]. Ann Allergy Asthma Immunol 114(3):208–213PubMedCrossRef

11.

Chupp GL, Lee CG, Jarjour N et al (2007) A chitinase-like protein in the lung and circulation of patients with severe asthma[J]. N Engl J Med 357(20):2016–2027PubMedCrossRef

12.

Tang H, Fang Z, Sun Y et al (2010) YKL-40 in asthmatic patients, and its correlations with exacerbation, eosinophils and immunoglobulin E[J]. Eur Respir J 35(4):757–760PubMedCrossRef

13.

Specjalski K, Jassem E (2011) YKL-40 protein is a marker of asthma[J]. J Asthma 48(8):767–772PubMedCrossRef

14.

Konradsen JR, James A, Nordlund B et al (2013) The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma[J]. J Allergy Clin Immunol 132(2):328–335PubMedCrossRef

15.

Kim HR, Jun CD, Lee KS et al (2012) Levels of YKL-40 in pleural effusions and blood from patients with pulmonary or pleural disease[J]. Cytokine 58(3):336–343PubMedCrossRef

16.

Duru S, Yuce G, Ulasli SS et al (2013) The relationship between serum YKL-40 levels and severity of asthma[J]. Iran J Allergy Asthma Immunol 12(3):247–253PubMed

17.

Tsai Y, Ko Y, Huang M et al (2014) CHI3L1 polymorphisms associate with asthma in a Taiwanese population[J]. BMC Med Genet 15:86PubMedPubMedCentralCrossRef

18.

Shirai T, Hirai K, Gon Y et al (2019) Combined assessment of serum periostin and YKL-40 may identify asthma-COPD overlap[J]. J Allergy Clin Immunol Pract 7(1):134–145PubMedCrossRef

19.

Han SS, Lee WH, Hong Y et al (2016) Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease[J]. J Asthma 53(6):583–588PubMedCrossRef

20.

El BN, Osman HM, Abdelaal AA et al (2018) Increased expression of serum periostin and YKL40 in children with severe asthma and asthma exacerbation[J]. J Investig Med 66(8):1102–1108CrossRef

21.

Gon Y, Maruoka S, Ito R et al (2017) Utility of serum YKL-40 levels for identification of patients with asthma and COPD[J]. Allergol Int 66(4):624–626PubMedCrossRef

22.

Santos CB, Davidson J, Covar RA et al (2014) The chitinase-like protein YKL-40 is not a useful biomarker for severe persistent asthma in children[J]. Ann Allergy Asthma Immunol 113(3):263–266PubMedCrossRef

23.

James AJ, Reinius LE, Verhoek M et al (2016) Increased YKL-40 and chitotriosidase in asthma and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med 193(2):131–142PubMedCrossRef

24.

Rathcke CN, Johansen JS, Vestergaard H (2006) YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance[J]. Inflamm Res 55(2):53–59PubMedCrossRef

25.

Bara I, Ozier A, Girodet PO et al (2012) Role of YKL-40 in bronchial smooth muscle remodeling in asthma[J]. Am J Respir Crit Care Med 185(7):715–722PubMedCrossRef

26.

Tang H, Sun Y, Shi Z et al (2013) YKL-40 induces IL-8 expression from bronchial epithelium via MAPK (JNK and ERK) and NF-kappaB pathways, causing bronchial smooth muscle proliferation and migration[J]. J Immunol 190(1):438–446PubMedCrossRef

27.

Iwata T, Kuwajima M, Sukeno A et al (2009) YKL-40 secreted from adipose tissue inhibits degradation of type I collagen[J]. Biochem Biophys Res Commun 388(3):511–516PubMedCrossRef

28.

Bigg HF, Wait R, Rowan AD et al (2006) The mammalian chitinase-like lectin, YKL-40, binds specifically to type I collagen and modulates the rate of type I collagen fibril formation[J]. J Biol Chem 281(30):21082–21095PubMedCrossRef

29.

Zhu Z, Zheng T, Homer RJ et al (2004) Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation[J]. Science 304(5677):1678–1682PubMedCrossRef

30.

Lee CG, Hartl D, Lee GR et al (2009) Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis[J]. J Exp Med 206(5):1149–1166PubMedPubMedCentralCrossRef

31.

Matsuura H, Hartl D, Kang MJ et al (2011) Role of breast regression protein-39 in the pathogenesis of cigarette smoke-induced inflammation and emphysema[J]. Am J Respir Cell Mol Biol 44(6):777–786PubMedCrossRef

32.

Kanazawa J, Kitazawa H, Masuko H et al (2019) A cis-eQTL allele regulating reduced expression of CHI3L1 is associated with late-onset adult asthma in Japanese cohorts[J]. BMC Med Genet 20(1):58PubMedPubMedCentralCrossRef

33.

Liu L, Zhang X, Liu Y et al (2019) Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations[J]. Respir Res 20(1):95PubMedPubMedCentralCrossRef

34.

Ahangari F, Sood A, Ma B et al (2015) Chitinase 3-like-1 regulates both visceral fat accumulation and asthma-like Th2 inflammation[J]. Am J Respir Crit Care Med 191(7):746–757PubMedPubMedCentralCrossRef

35.

Sohn MH, Lee JH, Kim KW et al (2009) Genetic variation in the promoter region of chitinase 3-like 1 is associated with atopy[J]. Am J Respir Crit Care Med 179(6):449–456PubMedCrossRef

36.

Zhu Y, Yan X, Zhai C et al (2017) Association between risk of asthma and gene polymorphisms in CHI3L1 and CHIA: a systematic meta-analysis[J]. BMC Pulm Med 17(1):193PubMedPubMedCentralCrossRef

37.

Ober C, Tan Z, Sun Y et al (2008) Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function[J]. N Engl J Med 358(16):1682–1691PubMedPubMedCentralCrossRef

38.

Cunningham J, Basu K, Tavendale R et al (2011) The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults[J]. Ann Allergy Asthma Immunol 106(5):381–386PubMedCrossRef

39.

Li K, Chen Z, Qin Y et al (2019) Plasm YKL-40 levels are associated with hypertension in patients with obstructive sleep apnea[J]. Biomed Res Int 2019:5193597PubMedPubMedCentral

40.

Mutlu LC, Tulubas F, Alp R et al (2017) Serum YKL-40 level is correlated with apnea hypopnea index in patients with obstructive sleep apnea syndrome[J]. Eur Rev Med Pharmacol Sci 21(18):4161–4166PubMed

41.

Ragnoli B, Pochetti P, Raie A et al (2021) Interrelationship between obstructive sleep apnea syndrome and severe asthma: from endo-phenotype to clinical aspects[J]. Front Med (Lausanne) 8:640636CrossRef

42.

Peng J, Yu Q, Fan S et al (2021) High blood eosinophil and YKL-40 levels, as well as low CXCL9 levels, are associated with increased readmission in patients with acute exacerbation of chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis 16:795–806PubMedPubMedCentralCrossRef

43.

Hozumi H, Fujisawa T, Enomoto N et al (2017) Clinical utility of YKL-40 in polymyositis/dermatomyositis-associated interstitial lung disease[J]. J Rheumatol 44(9):1394–1401PubMedCrossRef

44.

Yang X, Sheng G (2018) YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children[J]. BMC Pediatr 18(1):381PubMedPubMedCentralCrossRef

45.

Schultz NA, Johansen JS (2010) YKL-40-a protein in the field of translational medicine: a role as a biomarker in cancer patients?[J]. Cancers (Basel) 2(3):1453–1491CrossRef

Titel: Association between YKL-40 and asthma: a systematic meta-analysis
verfasst von: Yihan Jin
Jie Song
Fang Xu
Di Zhang
Jinfang He
Jiakun Zheng
Yanan Zhang
Jintong Li
Yikun Guo
Mengjiao Xu
Xiangfeng Yu
Yanbin Liu
Qinghua Liu
Jun Yan
Publikationsdatum: 16.10.2021
Verlag: Springer International Publishing
Erschienen in: Sleep and Breathing / Ausgabe 3/2022
Print ISSN: 1520-9512
Elektronische ISSN: 1522-1709
DOI: https://doi.org/10.1007/s11325-021-02495-w

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Association between YKL-40 and asthma: a systematic meta-analysis

Abstract

Purpose

Methods

Results

Conclusion

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2022

Periodic limb movements during sleep are associated with poor health-related quality of life in patients with obstructive sleep apnea

Secondhand smoke is associated with poor sleep quality in self-reported never-smokers of Northwest China: a cross-sectional study

Knowledge, attitudes, and practice patterns of obstructive sleep apnea among speech-language pathologists

Effect of allergic rhinitis on sleep in children and the risk factors of an indoor environment

Correction to: Melatonin prevents chronic intermittent hypoxia-induced injury by inducing sirtuin 1-mediated autophagy in steatotic liver of mice

Sleepiness in obstructive sleep apnea using hypopneas defined by a 3% oxygen desaturation or arousal but not by 4% or greater oxygen desaturation

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin